Monthly Archives: April 2006

Featured Stories

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Former FDA Commissioner Under Investigation

The tenure of Dr. Lester M. Crawford as FDA Commissioner was a short one, with his resignation in September coming less than three months after his confirmation. Dr. Crawford’s stay at the FDA as deputy commissioner, acting commissioner, and then … Continue reading

Posted in Health Concerns, Legal News |

First Treatment for Pompe Disease Approved by FDA

The FDA has announced the approval of “a biologics license application (BLA) for Myozyme (alglucosidase alfa, rhGAA), the first treatment for patients with Pompe disease, a rare but severely debilitating disease. Pompe disease, which affects one in 40,000-300,000 individuals, drastically … Continue reading

Posted in Health Concerns |

Unstable TVs Pose Serious Risk to Children

A review of records for the past 10 years indicates that the Consumer Product Safety Commission (CPSC) has announced eight recalls for various types of TV tables or TV stands that had the potential of allowing an unstable television to … Continue reading

Posted in Defective Products, Product Recalls |

Return of Direct-To-Consumer Celebrex Ads Demonstrates the Pivotal Role this Controversial Sales Tool Plays In Drug Marketing

By Steven DiJoseph The saga of the class of drugs known as COX-2 inhibitors has provided an ongoing glimpse into a number of aspects of the multi-billion dollar pharmaceutical industry. These so-called “super aspirins,” were seen by critics as over-priced … Continue reading

Posted in Health Concerns, Legal News |

Timeline Keeps Getting Worse for Bausch & Lomb with Respect to Knowledge of Eye Infections

By Steven DiJoseph No sooner had the ink dried on a Wall Street Journal report that Bausch & Lomb had learned of eye infections linked to its ReNu With Moisture-Loc from Hong Kong health officials in November 2005, than the … Continue reading

Posted in Health Concerns, Legal News |

Deutsche Bank Building Continues to Generate Controversy at ‘Ground Zero’

The now infamous black skyscraper was once an integral part of the Wall Street financial district standing in the shadow of the twin towers of the World Trade Center (WTC). Then came September 11, 2001 and, from that day on, … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

CPSC Announces Recall of 55,000 Children’s Necklaces that Pose Lead Poisoning Hazard

The Consumer Product Safety Commission and Selected Trading Corp. of Miami, Florida, have announced the voluntary recall of about 55,000 Children’s Necklaces manufactured in China that pose a danger of lead poisoning to children. Consumers should stop using recalled products … Continue reading

Posted in Defective Products, Product Recalls |

First of Over 4,000 Prempro Cases Set to Go to Trial in July

At about the same time pharmaceutical giant Merck will be entering its second year of trials in the massive Vioxx litigation consisting of some 12,000 cases, Wyeth, another major drugmaker, will be starting the first trial involving its menopausal treatment, … Continue reading

Posted in Health Concerns, Legal News |

Report Indicates Number of Americans without Health Insurance Has Increased Dramatically

A report by the Commonwealth Fund, a private, health care policy foundation has found that there has been a significant rise in the percentage of moderate- to middle-income working age Americans who did not have health insurance for some part … Continue reading

Posted in Health Concerns |

CPSC Announces Recall of 48,000 Hoist Exercise Benches for Finger Laceration and Amputation Hazard

The Consumer Product Safety Commission and Hoist Fitness Systems, Inc. have announced the voluntary recall of about 48,000 Hoist Exercise Benches manufactured in China. Consumers should stop using recalled products immediately. Hoist Fitness Systems Inc., also does business as Body … Continue reading

Posted in Defective Products, Product Recalls |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.